Meet the preclinical and translational scientists choosing models, reagents and platforms for UK and European cancer programmes, in a two-day room built for booked conversations.
Sponsor London 2027
Our sponsorship team replies within one working day.
Trusted by sponsors from our London 2026 launch edition

For suppliers of research tools, reagents, cell lines, in vivo models, lab automation and preclinical services, ImmunoMark Summit is a cancer conference London research teams use to compare approaches before they commit lab spend.
The 2nd annual London edition (3–4 March 2027) is built around two parallel streams, Next-Gen Immuno-Oncology and Biomarkers & Companion Diagnostics. Both are heavy on preclinical and translational science: myeloid checkpoints, logic-gated CAR T, allogeneic cell therapy, spatial and functional biomarkers. Those programmes run on the products you sell, and the people running them are in the room for two days.
That split matters for a research supplier. The scientists who run the experiments and the heads of discovery or translational medicine who approve the purchase order are both present, so a conversation that starts at the bench can reach a decision in the same week. With 60% of delegates from the UK and Ireland and 40% from the rest of Europe, the room covers UK academic groups and spin-outs as well as European biotech labs.
Research suppliers were already part of the mix in 2026: PromoCell, Miltenyi Biotec, Hologic Diagenode, HistologiX and HAWK Biosystems were among the companies on the floor at London 2026.
Most research suppliers already budget for at least one large academic cancer meeting. The useful question is what a focused summit adds next to it. Here is the comparison from a supplier’s seat.
| Large academic cancer meeting | ImmunoMark London | |
|---|---|---|
| Who is in the room | Researchers across every tumour type, discipline and career stage | IO and biomarker scientists, with 55–60% from biotech and pharma and 10–15% academic |
| Purchasing authority | Mixed; many conversations are with people who influence rather than buy | 45–50% senior leadership, alongside the bench scientists they manage |
| How you meet people | Booth traffic and poster halls, competing with hundreds of stands | Pre-scheduled 20-minute 1:1 meetings chosen from full delegate profiles, plus a wishlist |
| Speaking opportunities | Abstract-driven and rarely open to vendors | Sponsor talk slots in your chosen stream on Day 1 or Day 2 |
| Follow-up | Badge scans from the stand | Delegate list with contact details at every package tier |
| Academic and industry contact | Mostly academic | Academic group leaders and biotech discovery teams in the same sessions |
The large meeting still has a job: broad awareness across academic labs. ImmunoMark does a different one. It concentrates the translational buyers who move a tool from a published method into an industry programme, where order volumes and repeat purchasing tend to sit. Among the cancer conferences UK suppliers can staff with a small team, it is one of the few where a 20-minute meeting with a named head of discovery is booked before you arrive.
These are real sessions from the London 2027 agenda. Each one draws a group of scientists whose work depends on models, reagents, imaging or data tools.
Read the list as a map of demand. Cell-line, primary-cell and in vivo model providers will find their buyers in the myeloid and allogeneic sessions. Antibody and reagent suppliers fit the bispecific and multispecific session. Imaging, spatial and multiplex vendors belong next to the digital pathology and programmable platform talks, and data and automation companies next to the AI protein design work. The speaker faculty also includes a senior data scientist from The Francis Crick Institute and the C-Further programme lead from LifeArc.
Research buyers want to see data and talk to an application scientist. Choose a package that gives you a talk slot to show application data, a stand for demonstrations, and meetings to follow up. Every tier includes the delegate list with contact details and post-event branding.
A 30-minute talk on Day 2, pre-lunch, lands straight after the morning science sessions, when your buyers are thinking about methods.
For catalogue reagent and consumables suppliers who sell from the stand and follow up afterwards.
For suppliers who want every scientist in the building to see the brand, not only those who reach the stand.
Choose your stream by what your product touches. Cell and model suppliers usually fit Next-Gen Immuno-Oncology; spatial, multiplex and assay reagent suppliers usually fit Biomarkers & Companion Diagnostics. If you want meetings without a stand, the Exclusive 1:1 Meetings packages offer 3, 5, 7 or 10 meetings of 20 minutes. See all options on the London sponsorship page.
See what six meetings with discovery and translational leads could return on your average order.
Run the ROI calculatorIf you are comparing cancer conferences UK 2027 options, the deciding factor is usually how much of the two days you can plan in advance. This is what that looks like here.
Related pages: if your tools are immune-monitoring or cell-therapy focused, see the cancer immunotherapy view of London; for spatial, single-cell and discovery biomarker tools, the oncology biomarker page for the UK. Selling to US research groups as well? The San Diego research ecosystem page covers the February launch edition. For background on one of the most active tool categories in Stream 2, read spatial proteomics vs spatial transcriptomics. Of the oncology conferences UK 2027 offers a research supplier, this is the one built around booked conversations.
Get the London prospectus and see which stream slots are still open.
Request the prospectusPick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.
1. Choose a package
2. Your numbers
Year-one value of a new pharma or biotech customer
Booth visits, networking and questions after your talk
Share of conversations worth a proposal
Your typical close rate
Sponsorship plus travel and team costs
expected first-year revenue for every £1 of your event budget
Estimates only, based on the numbers you enter. Meetings and inclusions from the London 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.
What sponsors said
Here is what sponsors told us at our London 2026 launch edition.
We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Yes. Both streams carry a lot of preclinical and translational science, from myeloid checkpoint targets and allogeneic cell therapy to spatial transcriptomics and functional T cell biomarkers. Research suppliers including PromoCell, Miltenyi Biotec, Hologic Diagenode, HistologiX and HAWK Biosystems took part in London 2026.
The prospectus puts 10–15% of delegates in academic and research institutions and 55–60% in biotech and pharma. By role, 20–30% are scientists, principal investigators and technologists, and 45–50% are in senior leadership. You meet bench scientists and budget holders at the same event.
A large academic meeting gives broad awareness across many labs. ImmunoMark is smaller and more focused: you choose 20-minute 1:1 meetings from full delegate profiles, sponsor packages include a talk slot in your chosen stream, and every tier includes the delegate list with contact details for follow-up.
Yes. Platinum includes a 30-minute talk on Day 1, Gold a 30-minute talk on Day 2 before lunch and Silver a 15-minute talk on Day 2 after lunch, each in the stream you choose. The Headline sponsor has a 30-minute Day 1 keynote slot across both streams.
Platinum, Gold, Silver and Exhibitor packages include a 10 x 6 ft exhibition space with a table, two chairs and a power outlet. The Headline package has a 20 x 12 ft space with two tables, four chairs and two power outlets.
Tell us who you want to meet. We will send the prospectus, current package availability and a recommendation within one working day.